Ageing is associated with significant immunological changes that can influence both the progression of the disease and the ...

MS patients in the U.S. with Medicaid coverage have worse disease outcomes compared with those who have private insurance, a ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

People with multiple sclerosis (MS) face a significantly higher ... MS medications can have adverse effects or be poorly tolerated, and many patients pursue alternative treatments, despite the ...

The actress boosts awareness of MS as the West Hollywood-based neurologist works to limit its effect on patients ...

Over five years, relapsing-remitting multiple sclerosis patients in France taking Tysabri have adopted more at-home dosing, a review found.

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

The following is a summary of “Effect of patient-centered empowerment program through telenursing on self-management in ...

The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...